PROVIDER PROFILE · NPI 1689676520
Walter Loyola
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
14
Beneficiaries
—
Total drug cost
$351
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Celecoxib14 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Walter Loyola's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Gateway Diagnostic Imaging Llc Independent Diagnostic Testing Facility (IDTF) · Sherman, TX | 34 | 119 |
| SEO, EUNAE | 27 | 99 |
| Laboratory Corporation Of America Clinical Laboratory · Dallas, TX | 26 | 75 |
| Kirk Leblanc Anesthesiology · Dallas, TX | 22 | 66 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE